BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 11642030)

  • 1. Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.
    Özen M; Yılmaz S; Özkan T; Özer Y; Pekel AA; Sunguroğlu A; Gürman G; Arslan Ö
    Turk J Haematol; 2018 Mar; 35(1):54-60. PubMed ID: 28533197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis and transfusion management in a rare case of cis-AB blood group: A report from India.
    Datta SS; Rophina M; Scaria V
    Transfus Clin Biol; 2024 Feb; 31(1):31-35. PubMed ID: 37805160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rare red blood group discovered by a blood group discrepancy: a case report].
    Aissa W; Chouaieb S; Bellil N; Kaabi H; Hmida S
    Ann Biol Clin (Paris); 2024 Feb; 81(6):645-648. PubMed ID: 38189423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance in A₂ and A₂B phenotype frequency of ABO group in South India.
    Shastry S; Bhat S
    Blood Transfus; 2010 Oct; 8(4):267-70. PubMed ID: 20967168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of A1 and A2 Subtypes Among Whole-Blood Donors With Blood Groups A and AB at the Blood Center of a Tertiary Care Institute in Chhattisgarh.
    Wasnik M; Lahare S; Chandrakar R; Kashyap NK
    Cureus; 2024 Mar; 16(3):e57013. PubMed ID: 38681295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of A2 and A2B Subgroups among Blood Groups A and AB in healthy donors.
    Khanum A; Farhan S; Saqlain N; Arshad S
    Pak J Med Sci; 2024; 40(1Part-I):156-158. PubMed ID: 38196464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ax and Am antigens: possible diagnostic reagents to them].
    Potapov MI
    Sud Med Ekspert; 2005; 48(2):27-9. PubMed ID: 15881139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Final bedside verification: results of a national survey of reagents and devices used in France].
    Noizat-Pirenne F; Le Pennec PY; Lascaux JM; Fraval D; Zaoui F; Rouger P
    Transfus Clin Biol; 1998 Dec; 5(6):392-6. PubMed ID: 9894330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the fine specificity of ABO monoclonal reagents with A and B type-specific function-spacer-lipid constructs in kodecytes and inkjet printed on paper.
    Barr K; Korchagina E; Ryzhov I; Bovin N; Henry S
    Transfusion; 2014 Oct; 54(10):2477-84. PubMed ID: 24749871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Yes, we should keep ABO agglutination test within bedside transfusion checks].
    Daurat G
    Transfus Clin Biol; 2008 Nov; 15(5):322-6. PubMed ID: 18930425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of the removal of A2 test erythrocytes and the anti-AB reactant on the interpretation of the ABO blood grouping].
    Chiaroni J
    Transfus Clin Biol; 2001 Aug; 8(4):381-9. PubMed ID: 11642030
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.